Exelixis: Truist raises price target citing increased sales potential
Investing.com– Truist analysts have increased their price target (PT) for Exelixis Inc (NASDAQ:EXEL), reflecting greater confidence in the company’s growth prospects. Exelixis, a biotechnology firm specializing in oncology treatments, continues to gain momentum with its flagship drug, Cabometyx, and
BOJ will raise rates if economy, price conditions continue to improve, Ueda says
By Kentaro Sugiyama TOKYO (Reuters) -The Bank of Japan will raise interest rates and adjust the degree of monetary support if improvements in the economy and price conditions continue, Governor Kazuo Ueda said on Wednesday. The new U.S. administration’s economic policy and
Asia stocks inch up tracking Wall Street, spotlight on key US inflation data
Investing.com– Most Asian stocks edged higher on Wednesday tracking overnight rise on Wall Street, but gains were limited as investors remained cautious ahead of key U.S. inflation data, particularly in light of the Federal Reserve’s hawkish stance in December. U.S. stock
Country Garden overdue results show steep losses amid sector’s sales slump
By Clare Jim HONG KONG (Reuters) -Country Garden, once China’s biggest developer and now facing a liquidation lawsuit, reported steep losses on Tuesday in its long-overdue 2023 and interim 2024 financial results, hurt by large provisions amid a prolonged property sector